InflaRx NV diskutieren
Buy InflaRx NV
InflaRx (NASDAQ: IFRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
InflaRx (NASDAQ: IFRX) was upgraded by analysts at Lifesci Capital from a "market perform" rating to an "outperform" rating.
Ratings data for IFRX provided by MarketBeat
InflaRx (NASDAQ: IFRX) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $8.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
InflaRx (NASDAQ: IFRX) had its price target raised by analysts at HC Wainwright from $6.00 to $10.00. They now have a "buy" rating on the stock.
Ratings data for IFRX provided by MarketBeat
InflaRx (NASDAQ: IFRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
InflaRx (NASDAQ: IFRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
InflaRx (NASDAQ: IFRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
InflaRx (NASDAQ: IFRX) had its price target lowered by analysts at HC Wainwright from $9.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for IFRX provided by MarketBeat
InflaRx (NASDAQ: IFRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
InflaRx (NASDAQ: IFRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
InflaRx (NASDAQ: IFRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
InflaRx (NASDAQ: IFRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
InflaRx (NASDAQ: IFRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
InflaRx (NASDAQ: IFRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
InflaRx (NASDAQ: IFRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
InflaRx (NASDAQ: IFRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
InflaRx (NASDAQ: IFRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
InflaRx (NASDAQ: IFRX) had its price target raised by analysts at Guggenheim from $7.00 to $10.00. They now have a "buy" rating on the stock.
Ratings data for IFRX provided by MarketBeat
InflaRx (NASDAQ: IFRX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $10.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
Neueste Beiträge
HC_Wainwright in InflaRx NV diskutieren